AMJ Podcast | Episode 3: Shifting the Silence: The Evolving Landscape in Pulmonary Fibrosis

This content was funded by Boehringer Ingelheim, who had no influence or involvement in the development of the content. This material is intended for U.S. healthcare professionals. Pulmonary fibrosis remains one of the most challenging respiratory diseases – often underdiagnosed, undertreated, and misunderstood. In this AMJ podcast, Ayodeji Adegunsoye and Toby Maher share their expert perspectives on how the field is changing, how recent data are shaping clinical decision-making, and why holistic, patient-centered care is critical. Chapters:  03:02 – 15:34 – A Decade Without New Options 15:34 – 27:47 – Understanding the Latest Clinical Trial Data 27:47 – 39:28 – From Hesitancy to Action: Reaching the Community Clinician 39:28 – 54:10 – Psychosocial Support and Patient-Centered Care 54:10 – 01:02:07 – The Role of Primary Care in ILD Diagnosis 01:02:07 – 1:07:48 – Call to Action  Speakers: Ayodeji Adegunsoye, MD, PhD – Assistant Professor of Medicine, Biological Sciences Division, University of Chicago, Illinois, USA Toby Maher, MD, PhD – Professor of Clinical Medicine, Keck School of Medicine, University of Southern California, USA

There are no comments yet.

Please log in to write the first comment.